Home > Healthcare > Medical Devices > Therapeutic Devices > Home Infusion Therapy Market
Home Infusion Therapy Market size was worth more than USD 28.5 billion in 2022 and is anticipated to exhibit 11% CAGR from 2023-2032.
The high prevalence of hospital-acquired infections has elevated the demand for home infusion therapy devices in recent years. Unhygienic practices, non-sterile environments, and negligence of infection control procedures have intensified the cases of infections caused by fungal, viral, and bacterial pathogens in healthcare facilities.
Catheter-associated urinary tract infections (CAUTI) are one of the most common types of healthcare-associated infection that can be linked to using of unclean healthcare equipment and facilities. According to the data provided by the Stryker Corporation, nearly 449,334 cases of CAUTI are reported each year in the U.S. This scenario represents lucrative scope for home infusion therapy equipment providers in the forthcoming period.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Home Infusion Therapy Market Size in 2022: | 28.5 Billion (USD) |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 11% |
2032 Value Projection: | 81.5 Billion (USD) |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 144 |
Tables, Charts & Figures: | 135 |
Segments covered: | Product, Application, and Region. |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Growing safety concerns associated with home infusion therapy devices that are procured from local players may impede home infusion therapy market statistics. These devices showcase a certain risk of failure and safety issues for both patients and caregivers during administration. The U.S. Food and Drug Administration (FDA) has reported a myriad of challenges with infusion pumps, including software defects, damaged mechanical parts, performance failures, inadequate user interface design, and battery failures. The high risk of complications associated with these devices could negatively impact product sales.